Form 4: Ceribell Inc. Executive Receives Stock Options and RSUs

David Foehr, Senior VP of Finance and PAO at Ceribell, Inc., was granted restricted stock units and stock options on April 1, 2026.

Summary

• David Foehr, Senior VP of Finance and PAO at Ceribell, Inc., acquired 22,050 shares of Common Stock on April 1, 2026, with no cost associated.
• Additionally, Foehr was granted a stock option to buy 36,750 shares of Common Stock at an exercise price of $18.50, with an expiration date of April 1, 2036.
• The stock option shares are subject to vesting on each quarterly anniversary from May 20, 2026, contingent upon continued employment.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine executive compensation in the form of stock grants and options, without immediate financial performance indicators or significant strategic shifts.

Positives

• Grant of restricted stock units (RSUs) to a key executive, indicating potential alignment of executive interests with shareholder value.
• Grant of stock options to a key executive, providing an incentive for future stock price appreciation.
• The stock options have a long expiration date of April 1, 2036, allowing for a significant period of potential growth.

Negatives

• The exercise price of the stock options ($18.50) is significantly higher than the current market value implied by the RSU grant (effectively $0 cost). This suggests the stock price would need to more than double for the options to be immediately profitable.
• Vesting of stock options is tied to continued employment, which is standard but represents a potential forfeiture if employment ceases before vesting.

Risks

• The company's stock price may not appreciate sufficiently to make the stock options valuable by their expiration date.
• Continued employment is a condition for vesting, meaning any departure from the company prior to vesting dates could result in forfeiture of unvested options and RSUs.

Future Outlook

The vesting schedule for the stock options, starting May 20, 2026, and extending quarterly until April 1, 2036, indicates management's long-term commitment and expectation of sustained company performance and stock appreciation.

Industry Context

StockSavvy.ai notes that the granting of stock options and RSUs to senior executives is a common practice in the technology and biotech sectors, including companies like Ceribell, Inc., to incentivize performance and align executive interests with long-term shareholder value creation.

Stakeholder Impact

• Shareholders: The grants align executive incentives with potential future stock price appreciation, but the cost of options represents potential dilution if exercised.
• Employees: Standard executive compensation practice, may indirectly influence overall company morale and retention.
• Management: Reinforces commitment and provides financial incentive for continued service and performance.

Next Steps

• Continued employment by David Foehr to meet vesting requirements for stock options.
• Monitoring of Ceribell, Inc.'s stock performance relative to the $18.50 option exercise price.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Stock Options, Restricted Stock Units, Executive Compensation, Ceribell Inc., CBLL, Beneficial Ownership, Securities Exchange Act